Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 105 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: U54DK106846
Purdue University Center for Cancer Research
Grant: P30CA023168
National Science Foundation
Grant: 1943696
CAREER: Enhancing Stem Cell Differentiation with CRISPR Activators via Non-integrating Methods
National Science Foundation
Grant: 2143064
CAREER: Engineering ex vivo Human Cardiogenesis with Optogenetics
National Institute of General Medical Sciences
Grant: R35GM119787
National Heart, Lung, and Blood Institute
Grant: R35HL139599
National Institutes of Health
Grant: 5R35HL139599-02
Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease
National Institutes of Health
Grant: 3P30CA023168-35S1
Cancer Center Support Grant (CORE) Renewal
National Institutes of Health
Grant: 3R35GM119787-05S1
Role of microRNAs in neutrophil migration
National Institutes of Health
Grant: 5U54DK106846-03
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
FWCI
8.27
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals